Modelling menstrual status during and after adjuvant treatment for breast cancer

Statistics in Medicine

Volumn 25, Issue 20, 2006, Pages 3534-3547

  Szwarc, Suzanne E ^a   Bonetti, Marco ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOCCONI UNIVERSITY   (Italy)

Author keywords

Breast cancer; Competing risks; Cure rate model; Missing data

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; METHOTREXATE;

AMENORRHEA; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL OBSERVATION; CLINICAL TRIAL; DATA ANALYSIS; EXPERIENCE; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION PROCESSING; MATHEMATICAL ANALYSIS; MENOPAUSE; MENSTRUATION; METHODOLOGY; PARAMETRIC TEST; PREMENOPAUSE; PROCESS MODEL; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INTERNATIONALITY; MENSTRUAL CYCLE; MIDDLE AGED; MODELS, STATISTICAL;

EID: 33750056063     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2445     Document Type: Article

References (18)

1. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer. Journal of Clinical Oncology 1999; 17:2365-2370.
2. Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Edelmann DZ, Gudgeon A, Harvey V, Gelber RD. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. Journal of Clinical Oncology 2001; 19:1671-1675.
3. deHaes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W, Sauerbrei W. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + flourouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the zoladex early breast cancer research association trialists group. Journal of Clinical Oncology 2003; 21:4510-4516.
4. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP. Web-based survey of fertility issues in young women with breast cancer. Journal of Clinical Oncology 2004; 22:4174-4183.
5. Thewes B, Meiser B, Rickard J, Friedlander M. The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psycho-Oncology 2003; 12:500-511.
6. Peng Y, Dear KBG, Denham JW. A generalized F mixture model for cure rate estimation. Statistics in Medicine 1998; 17:813-830.
7. Gray RJ, Tsiatis AA. A linear rank test for use when the main interest is in differences in cure rates. Biometrics 1989; 45:899-904.
8. Laska EM, Meisner MJ. Nonparametric estimation and testing in a cure model. Biometrics 1992; 48:1223-1234.
9. Chen M, Ibrahim JG, Sinha D. A new Bayesian model for survival data with a surviving fraction. Journal of the American Statistical Association 1999; 94:909-919.
10. Farewell VT. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982; 38:1041-1046.
11. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in C: the Art of Scientific Computing (2nd edn). Cambridge University Press: New York, 1992.
12. Nocedal J, Wright SJ. Numerical Optimization. Springer: New York, 1999.
13. International Breast Cancer Study Group. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. Journal of the National Cancer Institute 2003; 95:1833-1846.
14. Brambilla DJ, McKinlay SM. A prospective study of factors affecting age at menopause. Journal of Clinical Epidemiology 1989; 42:1031-1039.
15. McKinlay SM. The normal menopause transition: an overview. Maturitas 1996; 23:137-145.
16. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association 1999; 94:496-509.
17. Lawless JF. Statistical Models and Methods for Lifetime Data (2nd edn). Wiley: New York, 2002.
18. Scharfstein DO, Robins JM. Estimation of the failure time distribution in the presence of informative censoring. Biometrika 2002; 89:617-634.